BYSI Stock Summary and Trading Ideas (Beyondspring - | NASDAQ:BYSI)

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

Beyondspring - trades on the NASDAQ stock market under the symbol BYSI.

As of April 2, 2026, BYSI stock price climbed to $1.73 with 2,320 million shares trading.

BYSI has a beta of -0.17, meaning it tends to be less sensitive to market movements. BYSI has a correlation of 0.00 to the broad based SPY ETF.

BYSI has a market cap of $70.94 million. This is considered a Micro Cap stock.

In the last 3 years, BYSI traded as high as $4.00 and as low as $.65.

The top ETF exchange traded funds that BYSI belongs to (by Net Assets): VXF, VTI, IWC.

BYSI has underperformed the market in the last year with a return of +9.9%, while SPY returned +17.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BYSI shares. However, BYSI has outperformed the market in the last 3 month and 2 week periods, returning +7.1% and +10.6%, while SPY returned -3.7% and -0.1%, respectively. This indicates BYSI has been having a stronger performance recently.

BYSI support price is $1.56 and resistance is $1.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BYSI shares will trade within this expected range on the day.